Medexus Pharmaceuticals Inc.
MEDXF
$3.64
-$0.02-0.57%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.37M | -2.39M | -272.00K | 381.00K | 806.00K |
| Total Depreciation and Amortization | 9.72M | 9.73M | 9.71M | 9.05M | 8.19M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.27M | 6.59M | 3.17M | 4.61M | 6.72M |
| Change in Net Operating Assets | -394.00K | 4.94M | 4.76M | 2.20M | 4.04M |
| Cash from Operations | 14.23M | 18.87M | 17.36M | 16.24M | 19.76M |
| Capital Expenditure | -51.00K | -154.00K | -204.00K | -246.00K | -276.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 653.00K | 653.00K | 653.00K | 653.00K |
| Cash Acquisitions | -2.98M | -2.90M | -4.43M | -4.40M | -3.20M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.50M | -15.00M | -7.50M | -2.54M | -5.04M |
| Cash from Investing | -17.53M | -17.40M | -11.49M | -6.54M | -7.87M |
| Total Debt Issued | 30.11M | 25.57M | 25.58M | -- | -- |
| Total Debt Repaid | -26.41M | -41.38M | -41.61M | -23.43M | -26.43M |
| Issuance of Common Stock | 495.00K | 495.00K | 19.30M | 19.30M | 19.30M |
| Repurchase of Common Stock | -3.04M | -1.53M | -375.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.76M | -2.08M | -2.48M | -3.06M | -3.87M |
| Cash from Financing | -605.00K | -18.92M | 418.00K | -7.19M | -11.00M |
| Foreign Exchange rate Adjustments | -84.00K | 0.00 | 238.00K | -111.00K | -17.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.99M | -17.45M | 6.53M | 2.41M | 878.00K |